Research Journal of Pharmacy and Technology

Community acquired pneumonia is one of the infectious diseases of the lungs with high morbidity and mortality rates. Rapid empirical antibiotic administration is needed to overcome this. Length of stay is one of the clinical outcomes in community acquired pneumonia, but until now there is no clear data related to the length of stay associated with the number of empirical antibiotics given to community acquired pneumonia patients. This study aims to see the difference in the length of stay between monotherapy and polytherapy patients. The research method used was descriptive analytic with a cross-sectional approach with the study sample including patients with a diagnosis of community acquired pneumonia and hospitalized who met the inclusion and exclusion criteria. Data collection was taken from medical record data in one of public hospital Bali in 2019. The collected data were analyzed univariately and bivariately. The results obtained from this study were that there was no difference in the median length of stay between monotherapy and polytherapy patients, both of which had a median of 5 days, while significant differences (p=0.01) were seen in the mean length of hospitalization between patients with monotherapy (4.88±2.14) and polytherapy (7.09±3.39) tested by the mann whitney. Further research is needed to clarify the relationship between the addition of empirical antibiotics and length of stay community pneumonia patients.